Tech Company Financing Transactions
Augmedics Funding Round
Augmedics, operating out of Arlington Heights, secured $82.5 million from CPMG, Almeda Ventures and Evidity Health Capital.
Transaction Overview
Company Name
Announced On
6/27/2023
Transaction Type
Venture Equity
Amount
$82,500,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to expand its US commercial presence as well as the delivery of its platform advancements which will enable mass-scale adoption of the xvision technology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
21 S. Evergreen Ave. 230
Arlington Heights, IL 60005
USA
Arlington Heights, IL 60005
USA
Phone
Undisclosed
Website
Email Address
Overview
Augmedics develops xvision -- an Augmented-Reality Head-Mounted Display for spine surgery. xvision allows surgeons to see the patient's anatomy through skin and tissue, as if they had X-Ray Vision?. Based on Augmedics' patented technology, the xvision system can project the patient's anatomy, in real time, directly onto the surgeon's retina, with surgical precision and outstanding depth perception.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nissan Elimelech
Chief Technical Officer
Stuart Wolf
President
Timothy Murawski
VP - Regulatory Affairs
Tami Harel
VP - Sales
Scott Finger
Browse more venture capital transactions:
Prev: 6/27/2023: Half Magic venture capital transaction
Next: 6/27/2023: Levit venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs